万元童颜针价格被打至4999元，医美巨头遭上游厂商拉黑

Core Viewpoint - The ongoing conflict between upstream manufacturers and downstream medical beauty institutions highlights the challenges in product authorization and market pricing within the medical aesthetics industry, indicating a shift from "wild growth" to "regulated development" in China’s medical beauty market [4][5]. Group 1: Industry Dynamics - The medical beauty industry is experiencing a tug-of-war over product pricing and authorization, with companies like Purity and New Oxygen at the forefront of this conflict [4][5]. - New Oxygen's low pricing strategies for products like "Miracle Youth 3.0" have disrupted traditional pricing structures, leading to tensions with upstream manufacturers [8][9]. - The market for youth-enhancing products, such as the "童颜针" (youth needle), has seen rapid growth, with estimates suggesting it will reach a scale of 100 billion in five years, up from over 30 billion last year [7]. Group 2: Compliance and Regulation - There are significant compliance concerns regarding the sourcing of medical products, with allegations that New Oxygen has used products without proper authorization, raising questions about product safety and traceability [11][12]. - Legal experts emphasize the importance of purchasing medical devices from authorized sources to ensure compliance with regulations, highlighting the potential penalties for non-compliance [12]. - The medical beauty industry faces challenges with counterfeit products and unauthorized sales, necessitating stronger regulatory measures and consumer awareness [15][16]. Group 3: Consumer Safety and Market Integrity - The prevalence of unauthorized medical beauty institutions and counterfeit products poses a significant risk to consumer safety, with only 35% of products in circulation being genuine [9][15]. - Industry leaders argue that lowering prices for legitimate medical beauty services is essential to combat the prevalence of "black medical beauty" practices, which thrive on high prices in the legitimate market [9][10]. - There is a call for a collaborative approach among manufacturers, medical institutions, and regulatory bodies to ensure consumer rights and product quality are prioritized in the evolving medical beauty landscape [17].